Recent Post

Aussie biotech appoints American royalty to its Board of Directors

VIVA! Communications are thrilled to be working with Australian medical technology company Medibio as they today (June 4, 2017) announce the appointment of mental health advocate and former U.S. congressman, Patrick J.  Kennedy, to their Board of Directors. Patrick J. Kennedy is a former member of the U.S. House of Representatives and America’s leading political…

Read More

Government adds $142 million in medicines to PBS

As of July 1, 2017, the Federal Government has made AUD$142 million in new medicine listings to the Pharmaceutical Benefits Scheme (PBS), in a bid to make more medicines affordable to all Australians. Among the new listings, the PBS will fund access to vorinostat to treat patients living a subtype of blood cancer, non-Hodgkin’s lymphoma called…

Read More

Scientific breakthrough on objective diagnosis of PTSD

Findings from an Emory University, USA research study* released this week demonstrate a non-invasive protocol involving heart rate data and machine learning algorithms can accurately diagnose post-traumatic stress disorder (PTSD). The Classification of post-traumatic stress disorder from heart rate variability metrics with heart rate-based window segmentation study, involving technology developed by Emory University and licensed…

Read More

Promising vaccination that lowers cholesterol could prevent heart attacks

A promising new vaccination that is designed to prevent heart attacks is currently being developed by Austrian biotech company, AFFiRis. The research has shown that the injection can be targeted towards the immune system to lower cholesterol by stopping fatty deposits from clogging the arteries and reducing the risk of heart disease. The vaccine, known…

Read More